STL Index for: Samantha R. Adam
Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition
Discover how zasocitinib, a next-generation selective TYK2 inhibitor, may redefine psoriasis treatment with targeted efficacy, reduced off-target JAK effects, and promising late-stage clinical results.
